Form 4: Willis Towers Watson Executive Acquires Additional Restricted Share Units Through Deferral Plan

Sentiment:

Insider Transaction Report


Willis Towers Watson's President of Health, Wealth & Career, Julie J. Gebauer, reported the acquisition of 1.0965 restricted share units through a company deferral plan.

Summary

  • Julie Jarecke Gebauer, President-Health, Wealth & Career at Willis Towers Watson PLC, reported the acquisition of 1.0965 Restricted Share Units (RSUs).
  • The acquisition occurred on July 11, 2025, with the underlying Ordinary Shares valued at $307.32 per share at the time of acquisition.
  • These RSUs were acquired through a participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
  • Following this transaction, Gebauer directly beneficially owns 5,340.8779 Restricted Share Units.
  • The vested RSUs will settle for Ordinary Shares on a 1:1 basis on the first business day of the month when the NASDAQ Stock Market is open, following the earlier of six months after the reporting person's separation from service or 30 days after their death.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction filing, indicating an executive's participation in a company deferral plan, which is neither significantly positive nor negative for the company's immediate outlook.

Positives

  • The executive's continued participation in the company's non-qualified deferral plan demonstrates ongoing alignment with company performance.
  • The transaction results in an increase in the executive's direct beneficial ownership of company securities.

Future Outlook

Vested Restricted Share Units will settle for Ordinary Shares on a 1:1 basis on the first business day of the month when the NASDAQ Stock Market is open, following the earlier of six months after the reporting person's separation from service or 30 days after their death.

Management Comments

  • Acquisition of restricted share units pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common for executives participating in company-sponsored compensation and deferral plans across various industries. It does not provide broader industry trends or competitive insights.

Related Party Transactions

  • Acquisition of restricted share units by an executive through a company-sponsored deferral plan, which is a standard related-party compensation mechanism.

Stakeholder Impact

  • Shareholders: Minor potential for future dilution upon RSU settlement, but generally reflects executive alignment with company performance through equity ownership.
  • Employees: Demonstrates the company's executive compensation and deferral programs are active.

Next Steps

  • Settlement of vested Restricted Share Units for Ordinary Shares on the first business day of the month when NASDAQ is open, following the earlier of six months after the reporting person's separation from service or 30 days after their death.

Key Dates

DateDescription
07/11/2025Date of earliest transaction and acquisition of Restricted Share Units.
07/15/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Keywords

Willis Towers Watson, WTW, SEC Form 4, insider transaction, restricted share units, RSU, executive compensation, deferral plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.